BioGaia's results for the third quarter to exceed market expectations
(Figures in the brackets refer to the same period the previous year) During the third quarter of 2022, BioGaia's sales have been positively impacted by increased demand, mainly in the Americas, as well as positive currency effects. For the third quarter, sales are preliminarily estimated at SEK 258 million (174), an increase of 48%. The operating profit for the third quarter is preliminarily estimated at SEK 94 million (67), an increase of 40%. BioGaia publishes the interim report for quarter three on Friday, October 21, 2022, at 08:00 am CEST, followed by an audiocast at 09:30 am